Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.69%)
As of: Sep 9, 2026 · 2:33 PM EDT

Viatris (VTRS) Tax Provisions (2019 - 2026)

Viatris (VTRS) posted Tax Provisions of $54.8 million for Q2 2026, up 112.93% on a QoQ basis from -$423.7 million in Q1 2026, and up 125.79% year-over-year from $24.3 million in Q2 2025.

Analysis

Viatris (VTRS) Tax Provisions (2019 - 2026) Analysis & Trends

Viatris has reported Tax Provisions for 8 years, with the latest figure at $54.8 million in Q2 2026.

  • On a quarterly basis, Tax Provisions rose 125.79% year-over-year to $54.8 million in Q2 2026; TTM through Jun 2026 was -$251.5 million, a 10.75% increase from a year earlier, with the FY2025 full-year figure at -$150.1 million, down 1464.55% from the prior year.
  • Tax Provisions was $54.8 million for Q2 2026 at Viatris, up from -$423.7 million in the prior quarter.
  • The five-year high for Tax Provisions was $457.7 million in Q4 2022, with the low at -$423.7 million in Q1 2026.
  • Average Tax Provisions over 5 years is $20.8 million, with a median of $61.9 million recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: Tax Provisions surged 2897.67% in 2025, then sank 670.36% in 2026.
  • Over 5 years, Tax Provisions stood at $457.7 million in 2022, then tumbled by 119.53% to -$89.4 million in 2023, then surged by 88.81% to -$10.0 million in 2024, then jumped by 71.0% to -$2.9 million in 2025, then soared by 1989.66% to $54.8 million in 2026.
  • The last three Tax Provisions figures came in at $54.8 million (Q2 2026), -$423.7 million (Q1 2026), and -$2.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Teva Pharmaceutical Industries 42.63 Bn 38.97 Bn 2.15 Bn 121.00 Mn
2 Viatris 19.19 Bn 18.30 Bn 1.46 Bn 54.80 Mn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 12.44 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn 1.38 Mn
5 Bausch Health Companies 2.36 Bn 520.30 Mn 2.10 Bn 88.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -59,000.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 12.40 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn 8.20 Mn
9 Fennec Pharmaceuticals 404.35 Mn 363.10 Mn 17.15 Mn 42,000.00
10 RedHill Biopharma 176.59 Mn 176.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.80 Mn
Mar 31, 2026 -423.70 Mn
Dec 31, 2025 -2.90 Mn
Sep 30, 2025 120.30 Mn
Jun 30, 2025 -212.50 Mn
Mar 31, 2025 -55.00 Mn
Dec 31, 2024 -10.00 Mn
Sep 30, 2024 -4.30 Mn
Jun 30, 2024 -65.40 Mn
Mar 31, 2024 90.70 Mn
Dec 31, 2023 -89.40 Mn
Sep 30, 2023 70.60 Mn
Jun 30, 2023 69.00 Mn
Mar 31, 2023 98.00 Mn
Dec 31, 2022 457.70 Mn
Sep 30, 2022 73.20 Mn
Jun 30, 2022 75.40 Mn
Mar 31, 2022 128.30 Mn
Dec 31, 2021 59.90 Mn
Sep 30, 2021 -111.60 Mn